Adverse event development in clinical oncology trials

Iris Walraven, Neil Aaronson, Jan-Jakob Sonke, Marcel Verheij, Jose Belderbos

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E263-E263
JournalLancet Oncology
Volume17
Issue number7
Publication statusPublished - Jul 2016

Cite this

Walraven, I., Aaronson, N., Sonke, J-J., Verheij, M., & Belderbos, J. (2016). Adverse event development in clinical oncology trials. Lancet Oncology, 17(7), E263-E263.